Document is current

Any future updates will be listed below

Slimming the risks: GLP-1 receptor agonist therapy may reduce in-hospital complications and hospital readmissions rates for hip fractures compared to obese patients not on these medications

Crossref DOI link: https://doi.org/10.1007/s00590-025-04477-0

Published Online: 2025-09-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark